Literature DB >> 12665576

NF-kappa B-dependent assembly of an enhanceosome-like complex on the promoter region of apoptosis inhibitor Bfl-1/A1.

Leonard C Edelstein1, Lynn Lagos, Matthew Simmons, Hemamalini Tirumalai, Céline Gélinas.   

Abstract

Expression of the prosurvival Bcl-2 homologue Bfl-1/A1 is induced by NF-kappa B-activating stimuli, while B and T cells from c-rel knockout mice show an absolute defect in bfl-1/a1 gene activation. Here, we demonstrate NF-kappa B-dependent assembly of an enhanceosome-like complex on the promoter region of bfl-1. Binding of NF-kappa B subunit c-Rel to DNA nucleated the concerted binding of transcription factors AP-1 and C/EBP beta to the 5'-regulatory region of bfl-1. Optimal stability of the complex was dependent on proper orientation and phasing of the NF-kappa B site. Chromatin immunoprecipitation analyses demonstrated that T-cell activation triggers in vivo binding of endogenous c-Rel, c-Jun, C/EBP beta, and HMG-IC to the bfl-1 regulatory region, coincident with selective recruitment of coactivators TAFII250 and p300, SWI/SNF chromatin remodeling factor component BRG-1, and basal transcription factors TATA-binding protein (TBP) and TFIIB, as well as hyperacetylation of histones H3 and H4. These results highlight a critical role for NF-kappa B in bfl-1 transcription and point to the need for a complex and precise regulatory network to control bfl-1 expression. To our knowledge, this is the first demonstration of enhanceosome-mediated regulation of a cell death inhibitor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12665576      PMCID: PMC152543          DOI: 10.1128/MCB.23.8.2749-2761.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  72 in total

1.  Role of Nr13 in regulation of programmed cell death in the bursa of Fabricius.

Authors:  R M Lee; G Gillet; J Burnside; S J Thomas; P Neiman
Journal:  Genes Dev       Date:  1999-03-15       Impact factor: 11.361

2.  Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis.

Authors:  R J Grumont; I J Rourke; S Gerondakis
Journal:  Genes Dev       Date:  1999-02-15       Impact factor: 11.361

3.  Human A1, a Bcl-2-related gene, is induced in leukemic cells by cytokines as well as differentiating factors.

Authors:  J S Moreb; M Schweder
Journal:  Leukemia       Date:  1997-07       Impact factor: 11.528

Review 4.  Initiation of acute phase response and synthesis of cytokines.

Authors:  A Koj
Journal:  Biochim Biophys Acta       Date:  1996-11-15

5.  Analysis of chromatin structure by in vivo formaldehyde cross-linking.

Authors:  V Orlando; H Strutt; R Paro
Journal:  Methods       Date:  1997-02       Impact factor: 3.608

6.  GRS, a novel member of the Bcl-2 gene family, is highly expressed in multiple cancer cell lines and in normal leukocytes.

Authors:  J J Kenny; T J Knobloch; M Augustus; K C Carter; C A Rosen; J C Lang
Journal:  Oncogene       Date:  1997-02-27       Impact factor: 9.867

7.  Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator.

Authors:  N D Perkins; L K Felzien; J C Betts; K Leung; D H Beach; G J Nabel
Journal:  Science       Date:  1997-01-24       Impact factor: 47.728

8.  The high mobility group protein HMG I(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene.

Authors:  D Thanos; T Maniatis
Journal:  Cell       Date:  1992-11-27       Impact factor: 41.582

9.  Jun is phosphorylated by several protein kinases at the same sites that are modified in serum-stimulated fibroblasts.

Authors:  S J Baker; T K Kerppola; D Luk; M T Vandenberg; D R Marshak; T Curran; C Abate
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

10.  CREB-binding protein/p300 are transcriptional coactivators of p65.

Authors:  M E Gerritsen; A J Williams; A S Neish; S Moore; Y Shi; T Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

View more
  35 in total

1.  NF-kappaB inhibits T-cell activation-induced, p73-dependent cell death by induction of MDM2.

Authors:  Valere Busuttil; Nathalie Droin; Laura McCormick; Francesca Bernassola; Eleonora Candi; Gerry Melino; Douglas R Green
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 2.  Metabolic stress in the myocardium: adaptations of gene expression.

Authors:  Peter A Crawford; Jean E Schaffer
Journal:  J Mol Cell Cardiol       Date:  2012-06-21       Impact factor: 5.000

3.  BAFF-R promotes cell proliferation and survival through interaction with IKKbeta and NF-kappaB/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells.

Authors:  Lingchen Fu; Yen-Chiu Lin-Lee; Lan V Pham; Archito T Tamayo; Linda C Yoshimura; Richard J Ford
Journal:  Blood       Date:  2009-03-03       Impact factor: 22.113

4.  TNF-induced oscillations in combinatorial transcription factor binding.

Authors:  Li Sun; Guozhe Yang; Mone Zaidi; Jameel Iqbal
Journal:  Biochem Biophys Res Commun       Date:  2008-03-31       Impact factor: 3.575

5.  Induction of the RelB NF-kappaB subunit by the cytomegalovirus IE1 protein is mediated via Jun kinase and c-Jun/Fra-2 AP-1 complexes.

Authors:  Xiaobo Wang; Gail E Sonenshein
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes.

Authors:  Valeriu B Cismasiu; Sailaja Ghanta; Javier Duque; Diana I Albu; Hong-Mei Chen; Rohini Kasturi; Dorina Avram
Journal:  Blood       Date:  2006-06-29       Impact factor: 22.113

7.  Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival.

Authors:  Lan V Pham; Archito T Tamayo; Linda C Yoshimura; Yen-Chiu Lin-Lee; Richard J Ford
Journal:  Blood       Date:  2005-08-11       Impact factor: 22.113

8.  Transitional B cells exhibit a B cell receptor-specific nuclear defect in gene transcription.

Authors:  Sarah F Andrews; David J Rawlings
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

9.  The Bcl-2 family member Bfl-1/A1 is strongly repressed in normal and malignant plasma cells but is a potent anti-apoptotic factor for myeloma cells.

Authors:  Karin Tarte; Michel Jourdan; Jean Luc Veyrune; Ingolf Berberich; Geneviève Fiol; Nicole Redal; John Shaughnessy; Bernard Klein
Journal:  Br J Haematol       Date:  2004-05       Impact factor: 6.998

10.  Identification of target genes for wild type and truncated HMGA2 in mesenchymal stem-like cells.

Authors:  Jørn Henriksen; Marianne Stabell; Leonardo A Meza-Zepeda; Silje Au Lauvrak; Moustapha Kassem; Ola Myklebost
Journal:  BMC Cancer       Date:  2010-06-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.